A concentrated, practice-focused update spanning benign and malignant hematology. Expert-led, case-based lectures translate evolving evidence and guidelines into clear diagnostic and treatment strategies you can apply immediately in clinic, hospital, and infusion settings.
What You Will Learn
How to streamline workups for anemia, cytopenias, coagulopathies, and thrombophilias
Evidence-based management of VTE: anticoagulant selection, duration, peri-procedural strategies
Current standards for leukemia, lymphoma, and myeloma—including frontline, relapsed/refractory, and maintenance approaches
Transfusion medicine pearls: product selection, thresholds, complications, and stewardship
Practical updates on targeted agents, immunotherapies, and cellular therapies—and how to manage toxicities
Supportive care essentials: infection prophylaxis, tumor lysis, TLS/SOS/VOD, and survivorship considerations
Event Details
Format: Live lectures with case discussions, board-style Q&A, and practical take-home checklists
Designed for: Rapid implementation in community and academic settings
Materials: Slide handouts and concise summaries for quick reference
Who Should AttendHematologists/oncologists, hospitalists, internal medicine physicians, advanced practice providers, pharmacists, and fellows seeking a high-yield, clinically oriented hematology refresh.
Why Attend
Convert complex trials and guidelines into simple, usable algorithms
Update your approach to diagnostics, therapeutics, and toxicity management
Leave with pragmatic tools to improve quality, safety, and patient outcomes
+ Topics:
Saturday, February 17, 2024
TIME
TOPIC
PRESENTER
07:00 AM – 08:00 AM
Breakfast | Visit Exhibit Hall
Exhibitors | Attendees
08:00 AM – 08:15 AM
Welcome | Introduction to Program
Robert S. Siegel, MD
Professor of Medicine, Associate Center Director for Education and Training, The George Washington University, GW Cancer Center
08:15 AM – 09:00 AM
Myeloproliferative Neoplasms
Ayalew Tefferi, MD
Barbara Woodward Lips Professor of Medicine, Mayo Clinic
09:00 AM – 09:45 AM
Multiple Myeloma
Kenneth Anderson, MD
Kraft Family Professor of Medicine
Dana-Farber Cancer Institute,
Harvard Medical School
09:45 AM – 10:00 AM
Break | Visit Exhibit Hall
Exhibitors | Attendees
10:00 AM – 10:45 AM
Disorders of Coagulation
Kenneth A. Bauer, MD
Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center
10:45 AM – 11:30 AM
Acute Myeloid Leukemia
Samah Nassereddine, MD
Assistant Professor of Medicine, The George Washington University, GW Cancer Center
11:30 AM – 12:15 PM
Bone Marrow Failure Syndromes, PNH, and MDS
Amy DeZern, MD, MHS
Associate Professor
The Johns Hopkins University School of Medicine
12:15 PM – 01:15 PM
Lunch | Visit Exhibit Hall
Exhibitors | Attendees
12:15 PM – 01:15 PM
Lunch Product Forum sponsored by Pfizer
Speaker- TBC
01:15 PM – 02:00 PM
Chronic Lymphocytic Leukemia
Imad A. Tabbara, MD
Chief, Division of Hematology/Oncology of DeCesaris Cancer Institute, Anne Arundel Medical Center, Clinical Professor of Medicine, The George Washington University
02:00 PM – 02:45 PM
Lymphoma
Nina Delaney Wagner-Johnston, MD
Director of Lymphoma Drug Development, The Sidney Kimmel Comprehensive Cancer Center, Professor of Oncology, The Johns Hopkins University School of Medicine
02:45 PM – 03:30 PM
Cellular Therapies
Catherine Bollard, MBChB, MD, FRACP, FRCPA
Professor of Pediatrics, Director, Center for Cancer and Immunology Research, Children’s National Hospital and The George Washington University
03:30 PM – 03:35 PM
Closing Remarks | Adjournment
Robert S. Siegel, MD
Professor of Medicine, Associate Center Director for Education and Training, The George Washington University, GW Cancer Center





Reviews
There are no reviews yet.